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Do primary care 
chaplains need training 
in mental health 
issues?
I read with interest Dr Macdonald’s 
article, which showed that talking therapy 
by chaplains resulted in an equivalent 
improvement in patient wellbeing as 
antidepressants.1
Leavey et al2 in an interview study 
concluded that clergy tend to explain mental 
health problems in terms of social factors 
with spiritual influences and for them the 
meaning of mental distress assumes more 
social and moral significance. Pennybaker 
et al3 have suggested there is a need to 
provide chaplains with training in psychiatric 
illness and to more clearly define their role 
in mental health care.
Dr Macdonald suggests primary care 
chaplaincy could be considered as an 
alternative to cognitive behavioural therapy 
but before adopting this strategy more 
widely it would be useful to obtain the views 
of chaplains on what talking therapy means 
to them and what training they would need 
to provide it.
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Incorporating cancer 
risk information into 
general practice: a 
qualitative study using 
focus groups with 
health professionals
Usher-Smith et al report a useful study 
in the potential utility of cancer risk 
assessment tools in general practice.1 
Readers may be interested to know that the 
www.qcancer.org tool, which calculates risk 
of a current but as yet undiagnosed cancer, 
was integrated into EMISWeb in 2016; the 
most popular GP computer system, used by 
over 55% of all GPs in the UK.
Also there is a new tool that predicts 
10-year risk of different types of cancer, 
taking account of family history and lifestyle 
as well as other risk factors that are readily 
available.2 There is an online calculator for 
women (http://qcancer.org/10yr/female/) and 
one for men (http://qcancer.org/10yr/male/).
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The wrong paradigm 
may be driving drug 
glucose control in the 
face of the evidence
Boussageon et al are the latest to highlight 
the apparent contradiction in our current 
thinking.1
On the one hand, the epidemiological 
evidence shows a strong link between 
chronic hyperglycaemia (HbA1c) and 
adverse patient-important outcomes. On the 
other hand, the evidence from randomised 
controlled trial shows that lowering HbA1c 
by drug treatment is ineffective or harmful 
to patient outcomes.
This contradiction is because we are 
using the wrong paradigm.
The current paradigm is that HbA1c has a 
causal relationship with adverse outcomes 
and that lowering HbA1c by any means 
must improve patient-important outcomes. 
The alternative paradigm is that chronic 
hyperglycaemia is partly causal, but is only 
a late and easily measurable part of a more 
fundamental problem.
Our culturally ‘normal’ diet, based on 
carbohydrate, is biologically different from 
the diet the human species evolved to thrive 
on. A large proportion of people cannot 
tolerate a carbohydrate-based diet over 
years, even ‘healthy whole grains’. Eating 
starch is eating glucose, which requires a 
corresponding insulin response. An insulin 
response with every snack and meal for years 
can, in genetically vulnerable people, cause 
insulin resistance with variable expression 
among people and among different body 
tissues. The Hyperinsulinaemia and Insulin 
Resistance (HAIR) is the underlying problem 
driving disorders of glucose and lipid 
metabolism, characterised by pathological 
fat deposition as central and visceral 
obesity, metabolic syndrome, and, when 
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